Results
43
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
43 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ABSO New | SEK 255.00 | 0.4% | -35.4% | SEK 2.9b | SEK 402.00 | PE22.9x | E24.8% | 1.2% | Capital Goods | ||
SUS New | SEK 159.10 | 1.9% | -10.7% | SEK 8.1b | SEK 192.17 | PE42x | E36.1% | n/a | Healthcare | ||
LIAB | SEK 226.40 | -3.7% | 14.1% | SEK 17.4b | SEK 263.67 | PE25.7x | E28.5% | 2.4% | Capital Goods | ||
NWG | SEK 174.80 | -4.5% | 6.6% | SEK 4.2b | SEK 168.25 | PE20.8x | E23.6% | 2.9% | Capital Goods | ||
NREST | SEK 107.60 | -1.3% | n/a | SEK 1.3b | SEK 155.00 | PE12x | E20.2% | n/a | Consumer Services | ||
SVED B | SEK 41.30 | 0% | 13.9% | SEK 2.2b | SEK 53.50 | PE17.1x | E23.0% | 2.4% | Capital Goods | ||
BMAX | SEK 44.94 | -4.1% | 19.1% | SEK 2.6b | SEK 48.00 | PE79.8x | E79.6% | 1.1% | Retail | ||
EQL | SEK 79.80 | -1.2% | 140.4% | SEK 2.3b | SEK 65.00 | PE74.4x | E53.3% | n/a | Healthcare | ||
MNTC | SEK 24.30 | -4.7% | -45.6% | SEK 621.3m | SEK 42.67 | PS2.3x | E116.7% | 0% | Healthcare | ||
VERT B | SEK 52.60 | -5.7% | 119.2% | SEK 1.4b | SEK 61.00 | PE39.5x | E44.4% | 0% | Software | ||
SVED BTA B | SEK 36.30 | 2.8% | n/a | SEK 1.9b | n/a | PE13.8x | E24.9% | n/a | Capital Goods | ||
EPRO B | SEK 69.10 | 0.6% | 27.7% | SEK 19.9b | SEK 76.33 | PE26.2x | E20.3% | 1.2% | Capital Goods | ||
FAG | SEK 54.00 | -2.7% | -15.9% | SEK 9.5b | SEK 72.00 | PE23.3x | E24.4% | 3.3% | Capital Goods | ||
TRUE B | SEK 50.25 | -5.6% | 45.6% | SEK 17.2b | SEK 63.17 | PE35.2x | E23.6% | 0.8% | Software | ||
BIOA B New | SEK 202.00 | 16.6% | -25.2% | SEK 17.9b | SEK 322.00 | PS106.8x | E62.5% | 0% | Pharmaceuticals & Biotech | ||
IAR B | SEK 125.50 | -8.4% | 0.6% | SEK 1.6b | SEK 200.00 | PS3.1x | E63.5% | 1.2% | Software | ||
XVIVO | SEK 473.00 | -0.3% | 48.7% | SEK 14.9b | SEK 538.17 | PE72.9x | E23.0% | n/a | Healthcare | ||
SINCH | SEK 19.99 | -8.8% | -44.4% | SEK 16.9b | SEK 32.50 | PS0.6x | E93.9% | n/a | Software | ||
NORVA | SEK 26.90 | -4.9% | 12.3% | SEK 4.9b | SEK 35.40 | PE25.9x | E21.2% | n/a | Commercial Services | ||
TFBANK | SEK 367.00 | 0.5% | 122.4% | SEK 7.9b | SEK 405.00 | PB3.1x | E27.1% | n/a | Banks | ||
NETI B | SEK 7.21 | -4.2% | 38.9% | SEK 2.5b | SEK 8.25 | PE29.4x | E22.5% | n/a | Tech | ||
AVEN | SEK 8.08 | 1.3% | -13.1% | SEK 300.0m | SEK 14.00 | PE18.2x | E22.9% | 0% | Software | ||
MAVEN | SEK 10.30 | 3.4% | -22.8% | SEK 534.6m | SEK 13.00 | PE30.1x | E31.8% | 1.0% | Tech | ||
BACTI B | SEK 37.90 | 14.2% | -39.1% | SEK 1.3b | SEK 55.00 | PS5.6x | E100.0% | n/a | Healthcare |